CRISPR THERAPEUTICS AG Earnings Per Share (Basic)
CRISPR THERAPEUTICS AG (CRSP) reported Earnings Per Share (Basic) of -$0.94 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-03
- CRISPR THERAPEUTICS AG earnings per share, basic for the quarter ending 2026-06-30 was -$0.94.
- CRISPR THERAPEUTICS AG earnings per share, basic for the quarter ending 2026-03-31 was -$1.28.
- CRISPR THERAPEUTICS AG earnings per share, basic for the quarter ending 2025-09-30 was -$1.17.
- CRISPR THERAPEUTICS AG earnings per share, basic for the quarter ending 2025-06-30 was -$2.40.
- CRISPR THERAPEUTICS AG earnings per share, basic for fiscal 2025 was -$6.47.
- CRISPR THERAPEUTICS AG earnings per share, basic for fiscal 2024 was -$4.34.
- CRISPR THERAPEUTICS AG earnings per share, basic for fiscal 2023 was -$1.94.
- CRISPR THERAPEUTICS AG earnings per share, basic for fiscal 2022 was -$8.36, a 268.21% decline from fiscal 2021.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.94 10-Q · filed 2026-08-03 | -$2.22 10-Q · filed 2026-08-03 | ||
| 2026-03-31 | -$1.28 10-Q · filed 2026-05-04 | |||
| 2025-12-31 | -$6.47 10-K · filed 2026-02-12 | |||
| 2025-09-30 | -$1.17 10-Q · filed 2025-11-10 | -$5.12 10-Q · filed 2025-11-10 | ||
| 2025-06-30 | -$2.40 10-Q · filed 2026-08-03 | -$3.98 10-Q · filed 2026-08-03 | ||
| 2025-03-31 | -$1.58 10-Q · filed 2026-05-04 | |||
| 2024-12-31 | -$4.34 10-K · filed 2026-02-12 | |||
| 2024-09-30 | -$1.01 10-Q · filed 2025-11-10 | -$3.92 10-Q · filed 2025-11-10 | ||
| 2024-06-30 | -$1.49 10-Q · filed 2025-08-04 | -$2.92 10-Q · filed 2025-08-04 | ||
| 2024-03-31 | -$1.43 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | -$1.94 10-K · filed 2026-02-12 | |||
| 2023-09-30 | -$1.41 10-Q · filed 2024-11-05 | -$3.07 10-Q · filed 2024-11-05 | ||
| 2023-06-30 | -$0.98 10-Q · filed 2024-08-05 | -$1.66 10-Q · filed 2024-08-05 | ||
| 2023-03-31 | -$0.67 10-Q · filed 2024-05-08 | |||
| 2022-12-31 | -$8.36 10-K · filed 2025-02-11 | |||
| 2022-09-30 | -$2.24 10-Q · filed 2023-11-06 | -$6.96 10-Q · filed 2023-11-06 | ||
| 2022-06-30 | -$2.40 10-Q · filed 2023-08-07 | -$4.72 10-Q · filed 2023-08-07 | ||
| 2022-03-31 | -$2.32 10-Q · filed 2023-05-08 | |||
| 2021-12-31 | $4.97 10-K · filed 2024-02-21 | |||
| 2021-09-30 | -$1.67 10-Q · filed 2022-11-01 | $6.85 10-Q · filed 2022-11-01 | ||
| 2021-06-30 | $10.01 10-Q · filed 2022-08-08 | $8.57 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | -$1.51 10-Q · filed 2022-05-09 | |||
| 2020-12-31 | -$1.50 10-K · filed 2021-02-16 | -$5.29 10-K · filed 2023-02-21 | ||
| 2020-09-30 | -$1.32 10-Q · filed 2021-11-03 | -$3.77 10-Q · filed 2021-11-03 | ||
| 2020-06-30 | -$1.30 10-Q · filed 2021-07-29 | -$2.44 10-Q · filed 2021-07-29 | ||
| 2020-03-31 | -$1.15 10-Q · filed 2021-04-27 | |||
| 2019-12-31 | $0.53 10-K · filed 2021-02-16 | $3.01 derived: net income ÷ weighted average shares · filed 2021-02-16 | $1.23 10-K · filed 2022-02-15 | |
| 2019-09-30 | $2.52 10-K · filed 2021-02-16 | $0.68 10-Q · filed 2020-10-28 | ||
| 2019-06-30 | -$1.01 10-K · filed 2021-02-16 | |||
| 2019-03-31 | -$0.93 10-K · filed 2021-02-16 | |||
| 2018-12-31 | -$0.92 10-K · filed 2020-02-12 | -$1.98 derived: net income ÷ weighted average shares · filed 2020-02-12 | -$3.44 10-K · filed 2021-02-16 | |
| 2018-09-30 | -$1.07 10-K · filed 2020-02-12 | -$2.51 10-Q · filed 2019-10-28 | ||
| 2018-06-30 | -$0.82 10-K · filed 2020-02-12 | |||
| 2018-03-31 | -$0.62 10-K · filed 2020-02-12 | |||
| 2017-12-31 | $0.00 10-K · filed 2019-02-25 | -$1.71 10-K · filed 2020-02-12 | ||
| 2017-09-30 | -$0.62 10-K · filed 2019-02-25 | |||
| 2017-06-30 | -$0.56 10-K · filed 2019-02-25 | |||
| 2017-03-31 | -$0.54 10-K · filed 2019-02-25 | |||
| 2016-12-31 | $0.43 10-K · filed 2018-03-08 | |||
| 2016-09-30 | -$2.77 10-K · filed 2018-03-08 | |||
| 2016-06-30 | -$3.15 10-K · filed 2018-03-08 | |||
| 2016-03-31 | -$1.53 10-K · filed 2018-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |